Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor

Details for Australian Patent Application No. 2006216732 (hide)

Owner Genentech, Inc.

Inventors Derynck, Mika K.; Kelsey, Stephen M.

Agent Griffith Hack

Pub. Number AU-B-2006216732

PCT Pub. Number WO2006/091693

Priority 60/655,277 23.02.05 US

Filing date 21 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 10 March 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/091693 Priority application(s): WO2006/091693

10 March 2011 Application Accepted

  Published as AU-B-2006216732

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216740-Tile alignment and leveling device and method for using same

2006216731-Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors